مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

231
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

109
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

Pages

  535-540

Abstract

 Background: Both oral contraceptive pills (OCPs) and Estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems that starting the gonadotropin-releasing hormone (GnRH) after 6 days of pre-treatment discontinuation may be important in IVF outcomes. Objective: The aim of the present study was to determine the number of mature oocyte and pregnancy rate of three pretreatment methods for fresh embryo transfer cycles. Materials and Methods: In this randomized controlled trial, two-hundred ten women (18-35 yr and less than 2 previous IVF attempts) undergoing IVF with the GnRH antagonist protocol were randomized to the OCP, E2, and no pretreatment arms. OCP group (n=53) received OCP (ethinyl Estradiol30 μ g and levonorgestrel150 μ g), E2 group (n=63) received 4 mg/day oral E2 (17β ‐ E2) for 10 days from day 20 of the previous cycle and GnRH antagonist stimulation was started 6 days after the interruption of OCP and E2. The control group (n =70) did not receive any pretreatment. Results: No significant difference was observed in the mean number of the mature oocyte, endometrial thickness, and embryo quality. The pregnancy rate in E2 group was higher than the two other groups (42. 9% vs 39. 6% and 34. 3% in OCP and control group, respectively), but the difference was not statistically significant (p=0. 59). Conclusion: It seems OCP or E2 pretreatment could not improve the fresh IVFembryo transfer outcomes.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SHAHROKH TEHRANINEJAD, ENSIEH, Bakhtiari Ghaleh, Fatemeh, ESLAMI, BITA, HAGHOLLAHI, FEDYEH, BAGHERI, MARYAM, & MASOUMI, MASOUMEH. (2018). Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT. INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), 16(8), 535-540. SID. https://sid.ir/paper/296537/en

    Vancouver: Copy

    SHAHROKH TEHRANINEJAD ENSIEH, Bakhtiari Ghaleh Fatemeh, ESLAMI BITA, HAGHOLLAHI FEDYEH, BAGHERI MARYAM, MASOUMI MASOUMEH. Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT. INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE)[Internet]. 2018;16(8):535-540. Available from: https://sid.ir/paper/296537/en

    IEEE: Copy

    ENSIEH SHAHROKH TEHRANINEJAD, Fatemeh Bakhtiari Ghaleh, BITA ESLAMI, FEDYEH HAGHOLLAHI, MARYAM BAGHERI, and MASOUMEH MASOUMI, “Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT,” INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE), vol. 16, no. 8, pp. 535–540, 2018, [Online]. Available: https://sid.ir/paper/296537/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button